CD79A and COVID-19: In summary, the present study is the first study to clearly show that the titers of IgM, IgG and IgA against the S protein, RBD, and N protein increased rapidly according to the maximum severity of COVID-19, especially in those who required supplemental oxygen at high flow rates.